CellFE
5 known investors
CellFE develops a microfluidic-based gene editing technology and a benchtop device for research and process development of cell therapies. Its products serve cell therapy researchers and developers, aiming to enable non-viral genome editing that maintains cell viability and scales from discovery to commercial manufacturing.